prescription-drug
  • Prescription Drug
  • Regulation

CMS Issues Pair of Rules on Line Item Extension Drugs

March 29, 2019

McDermott+Consulting

The Centers for Medicare and Medicaid Services (CMS) has issued an interim final rule revising the calculation of rebates for line item extension drugs and a final rule declining to finalize proposed regulatory change to the definition of “line item extension drugs.”

Comments on the rules are due in late May.

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope